Biotech

Biotech & Healthcare News

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 22.03.2022.

#mentalhealth
#HBAWOTY22
#HBAimpact
#AntimicrobialResistance
#antibiotics

Healthcare

@BIODeutschland shared
On Mar 22, 2022
RT @ITM_Radiopharma: Today we announced a EUR 33 m equity investment from ICIF & @PortlandCounsel. The capital increase follows the recently announced EUR 25 m equity investment from Grand Pharma, bringing the total in this financing round to EUR 58 m. See full announcement at https://t.co/lp6AZcCTcO https://t.co/mfuyPPXMHr
Open
ITM Receives EUR 33 Million Equity Investment to Advance Precision Oncology Pipeline of Targeted Radiopharmaceuticals

ITM Receives EUR 33 Million Equity Investment to Advance Precision Oncology Pipeline of Targeted Radiopharmaceuticals

ICIF and Portland Holdings add to recently secured EUR 25 million equity investment from Grand Pharma, bringing the total in this financing round to EUR 58 million recently …

@ldtimmerman shared
On Mar 17, 2022
How Evidation navigated the digital health world, and got into position to catch some tailwinds. 'The Shift' by @VentureValkyrie https://t.co/e5NThUzt9t
Open
Evidation: Finding Tailwinds For Pharma Companies, and Individual Patients

Evidation: Finding Tailwinds For Pharma Companies, and Individual Patients

Sailors know the concept of tacking. It’s an essential way of moving forward. Without tacking, the headwinds are too strong. The boat can go wildly off track, or stall. By steering from one ...

@SWLifeSciences shared
On Mar 17, 2022
Mental Health Co. Hosts Phase II Trials for LSD, Psilocybin: https://t.co/2pS0XRqRLF This mental health company is pioneering a unique, new treatment for issues such as depression & PTSD. $NM.CA $MNMD #mentalhealth @Novamind_Inc @mindmedco https://t.co/eoE6j2yuht
Open
Mental Health Co. Hosts Phase II Trials for LSD, Psilocybin

Mental Health Co. Hosts Phase II Trials for LSD, Psilocybin

This mental health company is pioneering a unique, new treatment for mental health issues such as depression and PTSD in which psychedelics are administered by medical professionals in ...

@WSJhealth shared
On Mar 22, 2022
Scientists find that three doses of China’s Sinovac vaccine had a clear benefit over two in preventing severe illness or death in people over the age of 60 https://t.co/SqrAJctfkL
Open
Hong Kong Data Show Benefit to Third Shot of Sinovac in Preventing Omicron Deaths

Hong Kong Data Show Benefit to Third Shot of Sinovac in Preventing Omicron Deaths

Study underscores the importance of booster shots for those who have received China’s Sinovac vaccine against Covid-19.

@Alnylam shared
On Mar 22, 2022
We're thrilled that Carol Pitcher-Towner, SVP, Global Patient Safety & Risk Management, has been recognized as a 2022 @HBAnet Luminary for her outstanding leadership and commitment to excellence. Congratulations to all the honorees! #HBAWOTY22 #HBAimpact https://t.co/flHxZ5TZt1 https://t.co/QvKwE22OhV
Open
2022 Luminaries

2022 Luminaries

The HBA Luminary award was introduced in 2014 as part of the HBA’s 25th anniversary of the Woman of the Year (WOTY). This year, the HBA is proud to recognize 84 senior women, identified by ...

@IFPMA shared
On Mar 21, 2022
Today, the world🌎is losing its most powerful tool in healthcare: #antibiotics. What steps do we need to take to address the threat of #AntimicrobialResistance (AMR)? @ThomasCueni as chair of @AMRAlliance outlines 4 priority actions in @HealthPolicyW⬇️ https://t.co/AGcOuX1f7x
Open
Four Priority Actions to Slow the Silent Pandemic of Antimicrobial Resistance

Four Priority Actions to Slow the Silent Pandemic of Antimicrobial Resistance

 Sadly, this is not an imaginary exercise. It’s a grim reality. It’s the world we’re living in today. In a biologically dictated race to survive, bacteria

@BIODeutschland shared
On Mar 16, 2022
Adrenomed Supervisory Board appoints Dr. Richard Jones as CEO https://t.co/BCfj0B6cQT
Open
Adrenomed Supervisory Board appoints Dr. Richard Jones as CEO

Adrenomed Supervisory Board appoints Dr. Richard Jones as CEO

Hennigsdorf/Berlin (Germany), 15 March, 2022 – Adrenomed AG, the vascular integrity company, today announced the appointment of Dr. Richard Jones as Chief Executive Officer of …